Nature Communications (Jun 2019)

A 3,2-Hydroxypyridinone-based Decorporation Agent that Removes Uranium from Bones In Vivo

  • Xiaomei Wang,
  • Xing Dai,
  • Cen Shi,
  • Jianmei Wan,
  • Mark A. Silver,
  • Linjuan Zhang,
  • Lanhua Chen,
  • Xuan Yi,
  • Bizheng Chen,
  • Duo Zhang,
  • Kai Yang,
  • Juan Diwu,
  • Jianqiang Wang,
  • Yujie Xu,
  • Ruhong Zhou,
  • Zhifang Chai,
  • Shuao Wang

DOI
https://doi.org/10.1038/s41467-019-10276-z
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 13

Abstract

Read online

In vivo decorporation of U(VI) from bones is an unsolved challenge because of the formation of stable uranium phosphate complexes. Here, the authors develop a hydroxypyridonone-based ligand with strong uranium complexation and low cytotoxicity. They find this ligand effectively removes uranium from kidney and bones in mice, and is suitable for oral administration.